1.
Clin Infect Dis
; 73(7): e1762-e1765, 2021 10 05.
Article
in English
| MEDLINE | ID: covidwho-1455264
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered virus for which remdesivir is the only antiviral available. We report the occurrence of a mutation in RdRP (D484Y) following treatment with remdesivir in a 76-year-old female with post-rituximab B-cell immunodeficiency and persistent SARS-CoV-2 viremia. A cure was achieved after supplementation with convalescent plasma.